PremierBiomedical-Logo-FINAL.jpg
Premier Biomedical Launches Hemp Oil Based Topical Pain Relief Ointment
January 23, 2018 10:25 ET | Premier Biomedical, Inc.
JACKSON CENTER, Pa., Jan. 23, 2018 (GLOBE NEWSWIRE) -- Premier Biomedical, Inc. (OTC:BIEI) announced introduction of a new hemp oil based topical ointment to complement its existing topical pain...
PremierBiomedical-Logo-FINAL.jpg
CEO William A. Hartman Interviewed on the Multi-Point Plan to Improve Premier Biomedical's Product Sales and Stock Performance
October 04, 2017 09:00 ET | Premier Biomedical, Inc.
Dallas, TX., , Oct. 04, 2017 (GLOBE NEWSWIRE) -- William A. Hartman, CEO of Premier Biomedical Inc. (OTCQB:BIEI) interviewed on the Uptick Network Stock Day Podcast with host Everett Jolly. Mr....
WSIIndustriesLogo.jpg
WSI Industries Announces Earnings Release Date
October 03, 2017 11:10 ET | WSI Industries, Inc.
Minneapolis, MN, Oct. 03, 2017 (GLOBE NEWSWIRE) -- WSI Industries, Inc. (Nasdaq: WSCI) today announced that it expects to release its fiscal 2017 fourth quarter and year-end financial results on...
Axim-Sapphire_Logo_-04 (1).png
AXIM Biotechnologies Reports Second Quarter 2017 Results
August 22, 2017 09:00 ET | AXIM Biotechnologies, Inc
NEW YORK, Aug. 22, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced results for the quarter...
PremierBiomedical-Logo-FINAL.jpg
CEO William Hartman Interviews on the Uptick Network Elaborating on Positive Plans for Continued Company Growth
August 15, 2017 09:30 ET | Premier Biomedical, Inc.
El Paso, TX , Aug. 15, 2017 (GLOBE NEWSWIRE) -- CEO William Hartman Interviews on the Uptick Network Elaborating on Positive Plans for Continued Company Growth El Paso, TX (UPTICK Newswire –...
Axim-Sapphire_Logo_-04 (1).png
AXIM Biotech to Present at 2017 Marcum Microcap Conference in New York City
June 14, 2017 09:00 ET | AXIM Biotechnologies, Inc
NEW YORK, June 14, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that George Anastassov,...
Synthetic Biology Market Growing With Rise In Medical Demand - IndustryARC
March 17, 2017 13:30 ET | IndustryARC
Hyderabad, India, March 17, 2017 (GLOBE NEWSWIRE) -- The report “Synthetic Biology Market: By Tool (XNAS, Chassis Organisms) By Technology (Bioinformatics, DNA sequencing, integrated systems) By...
Axim-Sapphire_Logo_-04 (1).png
AXIM Biotech Announces the Production of CanChew Plus™, the Next Generation Controlled Release CBD Chewing Gum
March 01, 2017 09:00 ET | AXIM Biotechnologies, Inc
NEW YORK, March 01, 2017 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (AXIM Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, began production of CanChew Plus™, the next...
Axim-Sapphire_Logo_-04 (1).png
AXIM Biotech to Attend the 19th Annual BIO CEO & Investor Conference in New York
February 09, 2017 09:00 ET | AXIM Biotechnologies, Inc
NEW YORK, Feb. 09, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that George E. Anastassov,...
Coherus BioSciences, Inc. logo
Coherus Announces Proposed Public Offering of Common Stock
February 07, 2017 16:04 ET | Coherus BioSciences, Inc.
REDWOOD CITY, Calif., Feb. 07, 2017 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), today announced it has commenced an underwritten public offering of $125,000,000 of shares of its...